University of Michigan researchers have successfully demonstrated a new technique that combines laser light with an FDA-approved fluorescent dye to monitor cell structure and activity at the molecular level. This could lead to improved clinical imaging and better monitoring of tumors and other cell structures. It could also be used during drug testing to monitor the changes that cells undergo when exposed to prospective new drugs.|Short Read

Mary-Ann Mycek, professor of biomedical engineering and associate chair for translational research in the Department of Biomedical Engineering, has been appointed associate dean for graduate education in the College of Engineering, effective September 1, 2016. |Short Read

A one-day crash course in tech entrepreneurship teaches students and post-docs how to evaluate the market potential of new technologies.|Medium Read

A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment. |Medium Read

In an entirely new approach to treating asthma and allergies, a biodegradable nanoparticle acts like a Trojan horse, hiding an allergen in a friendly shell to convince the immune system not to attack it.|Short Read

The new design, under development at Michigan, should be smaller and able to achieve higher resolutions than current 3D cameras.|Medium Read

A new imaging method uses infrared light to recover ultrasound images and chemical information from tissues inside the body - without breaking the skin.|Short Read

The approved antibiotic regimens may be failing to eradicate tuberculosis bacteria too often. A computer model could help fight antibiotic resistance.|Medium Read

A "dream team" of experts in sensors, electronics, data analysis and neuroscience has been awarded a $5 million grant to help unravel the mysteries of the brain and cross-train a group of internationally-connected neuroscientists and engineers.|Medium Read

A failed homemade cotton candy recipes ends up being the solution to a problem in the lab. |Medium Read

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.|Medium Read

A small, implantable device that researchers are calling a cancer "super-attractor" could eventually give doctors an early warning of relapse in breast cancer patients and even slow the disease’s spread to other organs in the body.|Medium Read